* LeMaitre Vascular Inc LMAT.OQ LMAT.O is expected
to show a
rise in quarterly revenue when it reports results on August 1.
* The Burlington Massachusetts-based company is expected to
report a 14.2% increase in revenue to $48.092 million from
$42.11 million a year ago, according to the mean estimate from 7
analysts, based on Refinitiv data. The company's guidance on May
2 2023, for the period ended June 30, was for revenue between
47.10 million and 49.50 million.
* Refinitiv's mean analyst estimate for LeMaitre Vascular
Inc is
for earnings of 32 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for LeMaitre
Vascular
Inc is $62.5, below its last closing price of $63.02.
The company's guidance on May 2 2023 for the period ended June
30 was for Earnings before Interest and Taxes between 8 million
and 9.6 million.The company's guidance on May 2 2023 for the
period ended June 30 was for gross profit margin of 65%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.25 0.25 0.27 Beat 7.4
Dec. 31 2023 0.26 0.26 0.25 Missed -3.3
Sep. 30 2022 0.27 0.28 0.25 Missed -9.9
Jun. 30 2022 0.27 0.27 0.16 Missed -39.6
Mar. 0.28 0.28 0.27 Missed -2.6
31 2022
Dec. 31 2021 0.31 0.31 0.28 Missed -8.6
Sep. 30 2021 0.33 0.33 0.30 Missed -7.7
Jun. 30 2021 0.35 0.34 0.40 Beat 18.2
This summary was machine generated July 29 at 01:45 GMT. All
figures in US dollars unless otherwise stated